New drug tested to boost blood health in diabetic kidney patients
NCT ID NCT07359027
Summary
This study tested if the drug Roxadustat could improve anemia (low red blood cells) in adults with moderate diabetic kidney disease. It involved 124 participants who took the drug for 24 weeks while researchers tracked their hemoglobin levels, iron markers, and quality of life. The goal was to see if this treatment could better manage this common complication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Second Xiangya Hospital, Central South University
Changsha, 410000, China
Conditions
Explore the condition pages connected to this study.